Abstract:Hypertension is both a health problem and a financial one globally. It affects nearly 30 % of the general population. Elderly people, aged ≥65 years, are a special group of hypertensive patients. In this group, the overall prevalence of the disease reaches 60 %, rising to 70 % in those aged ≥80 years. In the elderly population, isolated systolic hypertension is quite common. High systolic blood pressure is associated with an increased risk of cardiovascular disease, cerebrovascular disease, peripheral artery disease, cognitive impairment and kidney disease. Considering the physiological changes resulting from ageing alongside multiple comorbidities, treatment of hypertension in elderly patients poses a significant challenge to treatment teams. Progressive disability with regard to the activities of daily life, more frequent hospitalisations and low quality of life are often seen in elderly patients. There is discussion in the literature regarding frailty syndrome associated with old age. Frailty is understood to involve decreased resistance to stressors, depleted adaptive and physiological reserves of a number of organs, endocrine dysregulation and immune dysfunction. The primary dilemma concerning frailty is whether it should only be defined on the basis of physical factors, or whether psychological and social factors should also be included. Proper nutrition and motor rehabilitation should be prioritised in care for frail patients. The risk of orthostatic hypotension is a significant issue in elderly patients. It results from an autonomic nervous system dysfunction and involves maladjustment of the cardiovascular system to sudden changes in the position of the body. Other significant issues in elderly patients include polypharmacy, increased risk of falls and cognitive impairment. Chronic diseases, including hypertension, deteriorate baroreceptor function and result in irreversible changes in cerebral and coronary circulation. Concurrent frailty or other components of geriatric syndrome in elderly patients are associated with a worse perception of health, an increased number of comorbidities and social isolation of the patient. It may also interfere with treatment adherence. Identifying causes of non-adherence to pharmaceutical treatment is a key factor in planning therapeutic interventions aimed at increasing control, preventing complications, and improving long-term outcomes and any adverse effects of treatment. Diagnosis of frailty and awareness of the associated difficulties in adhering to treatment may allow targeting of those elderly patients who have a poorer prognosis or may be at risk of complications from untreated or undertreated hypertension, and for the planning of interventions to improve hypertension control.

How blood pressure variation is associated with frailty and mortality in the elderly

BLOOD PRESSURE VARIABILITY AND FRAILTY IN THE OLDER PEOPLE: THE HYPER-FRAIL-BPV STUDY

Blood Pressure in the Longevous Population with Different Status of Hypertension and Frailty.

Association between baseline office blood pressure level and the incidence and development of long-term frailty in the community-dwelling very elderly with hypertension

Analysis of systolic and diastolic blood pressure variability in frail, pre-frail, and non-frail elderly patients: The relationship between frailty syndrome and blood pressure variability in the elderly

Relationship Between Changes in Late-Life Blood Pressure and the Risk of Frailty and Mortality among Older Population in China: a Cohort Study Based on CLHLS

Blood pressure variability: A potential marker of aging

Association between control status of blood pressure and frailty among middle-aged and older adults with hypertension in China: a longitudinal study

ASSOCIATION OF BLOOD PRESSURE WITH MORTALITY IN OLDEST OLD PEOPLE WITH FRAILTY IN CHINA: RESULTS FROM CHINESE LONGITUDINAL HEALTHY LONGEVITY SURVEY (CLHLS)

Blood pressure, frailty status, and all-cause mortality in elderly hypertensives; The Nambu Cohort Study

Association Between Frailty and Mortality, Falls, and Hospitalization among Patients with Hypertension: A Systematic Review and Meta-Analysis

Frailty in Chinese older adults with hypertension: Prevalence, associated factors, and prediction for long-term mortality

Hypertension in frail older adults: current perspectives

Association between traditional cardiovascular risk factors and mortality in the oldest old: untangling the role of frailty

Association Between Orthostatic Hypertension and Frailty Among Older Patients With Hypertension

Hypertension and Frailty Syndrome in Old Age: Current Perspectives

Frailty and hypertension in older adults: current understanding and future perspectives

Blood pressure targets, medication consideration and unique concerns in elderly hypertension IV: Focus on frailty, orthostatic hypotension, and resistant hypertension

Blood pressure and dementia risk by physical frailty in the elderly: a nationwide cohort study

Changes in blood pressure associated with frailty and sarcopenia in elderly outpatients with cardiometabolic diseases

Correlates of Frailty in Hospitalized Older Adults with Hypertension and Its Influence on Clinical Prognosis